Terrence Flynn
Analyst, Morgan Stanley
Replay available
Johnson & Johnson (NYSE: JNJ) Q2 2025 earnings conference call, held 2025-07-16. Replay captured from the company's public earnings webcast.

Analyst, Morgan Stanley
Analyst, UBS
Chairman and Chief Executive Officer
Executive Vice President, Worldwide Chairman, MedTech
Analyst, Wells Fargo
Analyst, Guggenheim Securities
Chief Financial Officer
Analyst, RBC Capital Markets
Watch the replay and follow the connected company analysis, news, and investor updates for Johnson & Johnson.
WEBVTT 00:00:00.031 -- 00:00:04.936 Good morning and welcome to Johnson & Johnson's second quarter 2025 earnings conference 00:00:04.936 -- 00:00:09.020 call. All participants will be in listen-only mode until the question and answer session 00:00:09.020 -- 00:00:12.684 of the conference. This call is being recorded. 00:00:12.684 -- 00:00:16.207 If anyone has any objections, you may disconnect at this time. 00:00:16.207 -- 00:00:19.811 If you experience technical difficulties during the conference, you may press star zero 00:00:19.811 -- 00:00:23.935 to reach the operator. I will now turn the conference call over to Johnson & Johnson. 00:00:23.935 -- 00:00:26.356 You may begin. 00:00:26.626 -- 00:00:31.495 Hello, everyone. This is Darren Snellgrove, Vice President of Investor Relations for 00:00:31.495 -- 00:00:36.504 Johnson & Johnson. I am excited to be here today and to lead the investor 00:00:36.504 -- 00:00:41.253 relations team moving forward. Welcome to our 2025 00:00:41.253 -- 00:00:46.323 second quarter review of business results and updated financial outlook. 00:00:46.323 -- 00:00:52.050 First, a few logistics. As a reminder, today's presentation and associated schedules 00:00:52.050 -- 00:00:57.117 are available on the Investor Relations section of the Johnson & Johnson website at 00:00:57.117 -- 00:00:59.117 investor.jnj.com. 00:01:00.101 -- 00:01:04.888 Please note that this presentation contains forward-looking statements regarding, among 00:01:04.888 -- 00:01:10.635 other things, the company's future operating and financial performance, market position, 00:01:10.635 -- 00:01:12.728 and business strategy. 00:01:12.728 -- 00:01:16.835 You are cautioned not to rely on these forward-looking statements, which are based on 00:01:16.835 -- 00:01:21.843 the cu...